Oxford Global is proud to present the Oncology Clinical Development Congress. It is to be co-located with our 2nd Annual Oncology Biomarker Congress. Over the 2 days, the event provides a first class educational and networking opportunity for over 120 attendees to gain knowledge and insights into the Oncology Clinical Development market.
The event will bring together key scientists and investigators in oncology clinical trials, clinical R&D, adaptive trials, oncology diagnostics development, and translational research from leading pharmaceutical, biotechnology, diagnostics, clinical research companies and academic institutions in the UK and Europe. The programme feature topics on improving safety & risk assessment in Oncology clinical trials and clinical development by implementing biomarkers, manage patient selection & recruitment and identify potential cost savings through successful integration of companion diagnostics and enabling technologies in clinical development. Do not miss out on the opportunity to learn insights on effective development, design and analysis of clinical trials.